RxDoctor Payments Data

Kristie Young, DO

Family Medicine · Sevierville, TNNPI 1861526667

Payments from drug & device makers

$3,534in general payments, 2019–2025

Across 155 payments — averaging $22.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$1K
  • Paratek Pharmaceuticals, Inc.$583
  • AbbVie$355
  • Musculoskeletal Transplant Foundation Inc.$218
  • Melinta Therapeutics, LLC$149
  • Kerecis Limited$106
  • plus $752 from 26 others

What the payments were for

  • Food & beverage$3,534100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,534 in reported general payments places this provider in the 75th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$117,089
Medicare patients
153
Services billed
1,697

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SantylCollagenase Clostridium Hist.40$136,920
ErtapenemErtapenem Sodium85$36,757
Daptomycin93$22,499
Meropenem49$7,772
Linezolid28$1,345
Cefepime Hcl11$1,261
Doxycycline Hyclate67$670
Nystatin18$298
Ciprofloxacin Hcl32$268
Fluconazole21$221
Ampicillin Trihydrate12$215
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim29$180
Levofloxacin56$167
Prednisone11$38

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Smith+NephewSantyl$1,371$136,92040 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Sevierville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →